Wardman P, Clarke E D, Flockhart I R, Wallace R G
Br J Cancer Suppl. 1978 Jun;3:1-5.
This paper outlines the chemical background to the selection of compounds likely to be clinically superior to the nitroimidazoles currently being evaluated in cancer therapy. The most important chemical properties to consider are electron affinity and lipophilicity, and the quantification and prediction of both these properties are considered. Examples are presented of the use of multiple regression analysis to evaluate the relative contribution of individual properties to the overall biological response.
本文概述了选择可能在临床上优于目前癌症治疗中正在评估的硝基咪唑类化合物的化学背景。需要考虑的最重要的化学性质是电子亲和力和亲脂性,并对这两种性质的量化和预测进行了探讨。文中给出了使用多元回归分析来评估各个性质对整体生物学反应的相对贡献的示例。